Clariness and SubjectWell at SCOPE Summit 2026
SubjectWell and Clariness will be onsite at SCOPE 2026 at booths #1413-1415. If you’re attending, stop by to meet the team or join one of our informative sessions.
Attend our sessions
Wednesday, February 4 | 8:00 amUnderserved populations are often excluded from clinical trials, limiting engagement, scientific validity, and real-world relevance. Traditional strategies often rely on outdated assumptions and overlook patient realities. This session reveals proven, globally scalable strategies to engage these communities through real-world data (RWD), behavioral insights, and human-centered approaches—replacing guesswork with precision to accelerate inclusive trial enrollment and shorten study timelines. Tobias Kruse, PhD, Managing Director, Europe, SubjectWell
Wednesday, February 4 | 8:47 amPatient recruitment and engagement are major bottlenecks in clinical research. This session reveals how a Patient Experience Platform—integrating creative strategy, global reach, site/patient support, and advanced technology—transforms these challenges. Discover proven strategies to build trust, improve trial access, and retain patients. Learn how this approach leads to faster, more inclusive, and successful global clinical trials, with real-world examples. Fred Martin, CEO, SubjectWell
Thursday, February 5 | 8:30 am Join Suzanne as she delivers opening remarks as the track chairperson for Technology, Data and AI/ML for Intelligent Trial Design. Suzanne Harris, Senior Vice President, Marketing & Communications, SubjectWell
Thursday, February 5 | 9:00 am When it comes to patient recruitment, separating fact from fiction isn’t always easy. Joined by experts from Amgen, Bristol Myers Squibb, and Takeda, we’ll explore the 3 biggest myths shaping today’s clinical trial recruitment industry. George Dorsett, Senior Vice President, Sales, Marketing & Growth, Clariness
